ITeos Therapeutics Inc (ITOS) Live Stock Price, Forecast & News

ITeos Therapeutics Inc
ITOS
(Nasdaq - US)
N/A
11.65
+0.16 (+1.39%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
11.67
High
11.90
Low
11.53

Stats

Prev. Close

11.49

Open

11.67

Day's Range

11.53 - 11.90

52 Week Range

8.20 - 18.24

YTD Change

6.39%

1 Year Change

-13.12%

Market Cap

419.05M

P/E Ratio

N/A

Volume

9,317.00

Beta

1.27

Sector

Health Technology

Industry

Biotechnology

Economic CalendarAll Events

Time zone: GMT

Friday, May 3rd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:45	USD	S&P Global Services PMI FinalApr	Medium	51.3	50.9	51.7
14:00	USD	ISM Services PMIApr	High	49.4	52.0	51.4
23:45	USD	Fed Goolsbee Speech	Medium
23:45	USD	Fed Williams Speech	Medium

Saturday, May 4th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:20	USD	Fed Cook Speech	Medium
18:20	USD	Fed Cook Speech	Medium

Monday, May 6th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
16:50	USD	Fed Barkin Speech	Medium

Latest News

Zacks Investment ResearchFeb 26, 2024

Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?

ITOS+1.39%

Seeking AlphaJan 10, 2024

iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch

ITOS+1.39%

NVS-0.07%

Zacks Investment ResearchDec 13, 2023

Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Trade

ITOS+1.39%

Zacks Investment ResearchNov 27, 2023

Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?

ITOS+1.39%

Zacks Investment ResearchNov 13, 2023

Here's Why iTeos Therapeutics, Inc. (ITOS) Could be Great Choice for a Bottom Fisher

ITOS+1.39%

Zacks Investment ResearchNov 10, 2023

Wall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Know

ITOS+1.39%

Read All

Data Vendor: Xignite Logo

Stocks

ITeos Therapeutics Inc

Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?

iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch

Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Trade

Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?

Here's Why iTeos Therapeutics, Inc. (ITOS) Could be Great Choice for a Bottom Fisher

Wall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Know

Trade With A Regulated Broker